Inhibition of human leukocyte elastase by acetyl and trifluoroacetyl oligopeptide chloromethyl ketones. 1979

P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth

The action of human leukocyte elastase on a series of acetyl and trifluoroacetyl tri-, tetra-, and pentapeptide chloromethyl ketones has been investigated. Leukocyte and pancreatic elastases react quite differently with these irreversible inhibitors. For instance, leukocyte elastase has a much lower affinity for the compounds than pancreatic elastase. On the other hand, the inhibition rate constants of the two enzymes are not influenced in the same way by peptide chain elongation. The two elastases, however, share a common property: trifluoroacetyl tri- and tetraalanine chloromethyl ketones are more tightly bound but are less reactive than the corresponding acetylated inhibitors. This behavior is probably due to the formation of nonproductive complexes between the enzymes and the trifluoroacetylated inhibitors.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D010196 Pancreatic Elastase A protease of broad specificity, obtained from dried pancreas. Molecular weight is approximately 25,000. The enzyme breaks down elastin, the specific protein of elastic fibers, and digests other proteins such as fibrin, hemoglobin, and albumin. EC 3.4.21.36. Elastase,Pancreatopeptidase,Elastase I,Pancreatic Elastase I,Elastase I, Pancreatic,Elastase, Pancreatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth
February 1975, FEBS letters,
P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth
November 1977, Biochimica et biophysica acta,
P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth
July 1980, Biochimica et biophysica acta,
P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth
May 1978, The Journal of biological chemistry,
P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth
June 1990, Research communications in chemical pathology and pharmacology,
P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth
May 1987, Biochemistry,
P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth
February 1992, Journal of medicinal chemistry,
P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth
January 1973, Biochemistry,
P Lestienne, and J L Dimicoli, and A Renaud, and J G Bieth
May 1989, The European respiratory journal,
Copied contents to your clipboard!